A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ULMCA / unprotected left main coronary artery

[Related PubMed/MEDLINE]
Total Number of Papers: 183
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ULMCA  (>> Co-occurring Abbreviation)
Long Form:   unprotected left main coronary artery
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial. ARC, IVUS, LMCA, PCI, POCE
2022 Percutaneous coronary intervention in unprotected left main coronary artery stenosis: Mid-term outcomes of a single-center observational study. CABG, DES, MACCE, PCI
2021 Clinical Outcomes of Dialysis Patients Treated with Drug-Eluting Stent for Left Main Distal Bifurcation Lesions. DES, HD, HR, PCI, TLF, TLR
2021 Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry). CV, PCI
2021 Percutaneous coronary intervention versus coronary artery surgery for left main disease according to lesion site: A meta-analysis. CABG, CI, HR, MACE, PCI, RCTs
2021 Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry. CABG, EuroSCORE, MACCE
2021 Percutaneous Treatment of Unprotected Left Main Disease With Thin-Strut Durable-Polymer or Early Generation Thicker-Strutted and Coated Bioabsorbable-Polymer Drug-Eluting Stents in a Large-Scale Registry. DES, PCI, TLF
2021 Short- and Long-Term Prognosis of Intravascular Ultrasound-Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis Involving 24,783 Patients. IVUS, MI, PCI, RCTs, ST, TLR, TVR
2021 The Utility of Peripheral Intravascular Lithotripsy in Calcific Coronary Artery Disease: A Case Series. CAC, IVL, MACE
10  2021 [Long-term outcomes and risk factors of ostial/shaft lesions in unprotected left main coronary artery after percutaneous coronary intervention]. DES, LVEF, MI, PCI
11  2020 Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease. CI, HZ, MI, PCI, TLR
12  2020 Left ventricular systolic dysfunction in patients with unprotected left main coronary artery disease. CABG, DES, LVSD, PCI
13  2020 Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score. CABG, CI, MACE, MI, PCI, SYNTAX, TVR
14  2020 Long-term outcomes of single stenting compared with double stenting strategy for unprotected left main coronary artery disease: A protocol for systematic review and meta-analysis. ---
15  2020 Long-Term Outcomes of Unprotected Left Main Coronary Artery Disease: Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention. CABG, MACCE, MI, PCI, PSM, TVR
16  2020 Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization. CI, HR, TLR
17  2020 Percutaneous Coronary Intervention for Left Main Coronary Artery Bifurcation Lesions: Two-stent versus one-stent Strategy for Comparison of 6-month MACE. CABG, DS, KB, MACE, PCI, ss, TLR
18  2020 Twelve-year outcomes after revascularization for ostial/shaft lesions in unprotected left main coronary artery. CABG, DES, MI, PCI
19  2020 [Long-term outcome comparison of ostial/shaft lesions in unprotected left main coronary artery treated by PCI or CABG]. CABG, DES, MI, PCI
20  2019 Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial. DES, IVUS, MACEs, MI, ST, TVR
21  2019 Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis. CI, DES, HR, PCI
22  2019 Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization. CABG, MACCE, PCI
23  2019 Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis. CABG, PCI
24  2019 Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study. TLF
25  2018 Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis. CABG, DES, MI
26  2018 Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. MI, ST, TLR
27  2018 One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. MACEs, NSTEMI, PCI, STEMI, TIMI
28  2018 Orbital Atherectomy of Severely Calcified Unprotected Left Main Coronary Artery Disease: One-Year Outcomes. MACCE, PCI
29  2018 Outcome and selection of revascularization strategy in left main coronary artery stenosis. MACCE
30  2018 Sex difference among patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention in northern China. CAG, PCI
31  2018 Unprotected Left Main Coronary Artery Disease: Management in the Post NOBLE and EXCEL Era. CABG, PCI
32  2018 Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. BP-BES, DES, EES, MI, ST, TLR, ZES
33  2017 CABG Surgery Remains the best Option for Patients with Left Main Coronary Disease in Comparison with PCI-DES: Meta-Analysis of Randomized Controlled Trials. CABG, DES, PCI, RR, TVR
34  2017 Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease. CAD, CI, DM, EF, HR, MACCE
35  2017 Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival. AMICS, PCI, pLVAD
36  2017 Left main coronary stenosis: surgery still reigns. CABG, PCI, RCTs
37  2017 Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. CABG, CI, DES, OR, PCI
38  2017 Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main CoronaryNarrowing. CABG, DES, MI, ORs, PCI, RCTs
39  2017 Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing. CABG, CI, DES, MACCE, RCTs, RR
40  2017 Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. MACEs, PCI, PS, TLR
41  2017 Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial. DAPT, PCI
42  2017 [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery]. CABG, DES, HR, MI, PCI, PSM
43  2016 Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter? NSTEMI, PCI, STEMI
44  2016 Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India. LVEF, MACE
45  2016 Computing Methods for Composite ClinicalEndpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. CABG, PCI, TTE, WCE, WR
46  2016 Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents. CABG, CI, DESs, eGFRs, MI
47  2016 Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. ACS, CABG, DELTA, DES, MI, PCI
48  2016 Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience over 14 years. AMI, CS, OR, TIMI
49  2016 Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy. PCI
50  2016 Two-year clinical outcomes in stable angina and acute coronary syndrome after percutaneous coronary intervention of left main coronary artery disease. ACS, MACE, PCI, SAP
51  2016 Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease. CABG, DES, EF, MI, PCI
52  2015 Clinical comparison of percutaneous coronary intervention with domestic drug-eluting stents versus off pump coronary artery bypass grafting in unprotected left main coronary artery disease. CABG, DES, MACCE, MI, PCI, TVR
53  2015 Clinical Outcomes After Percutaneous Coronary Intervention in Acute Myocardial Infarction Due to Unprotected Left Main Coronary Artery Disease. AMI, PCI
54  2015 Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents. CI, DES, HR, ICR, MACE, PCI, PCR
55  2015 Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting. CABG, DES, PCI
56  2015 Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly. CI, HR, IVUS, MACE, PCI
57  2015 Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. CABG, OR, PCI, PIs
58  2015 One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions. PCI
59  2015 The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation. CABG, DES, PCI
60  2015 The STENTYS paclitaxel-eluting stent in the treatment of unprotected distal left main. DES, IVUS
61  2015 Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. DES, MI, PCI
62  2015 [Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization]. CABG, DES, MI, PCI
63  2014 Acute changes of left ventricular hemodynamics and function during percutaneous coronary intervention in patients with unprotected left main coronary artery disease. EDP, GLS, LV, PCIs
64  2014 Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions. IVUS, LAD, LCX, PSN-LCx
65  2014 Clinical outcomes of transradial unprotected left main coronary artery stenting in the elderly. MACE, PCI
66  2014 Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. IVUS
67  2014 Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). CABG, CI, CVA, MI, OR, PCI
68  2014 Drug-eluting stents in unprotected left main coronary artery disease. CABG, DES
69  2014 First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry. CI, DES, HR, MACE, MITO, PCI
70  2014 Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. CABG, CI, DES, HR, HR, MI, PCI
71  2014 Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). CABG, PCI
72  2014 Mortality in cardiogenic shock complicating acute myocardial infarction due to left main coronary artery disease: does gender matter? CS, MI, PL-ACS
73  2014 Percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion: status update 2014. AMI, CABG, NSTEMI, PCI, STEMI, TIMI
74  2014 Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing. CABG, PCI
75  2014 Safety and feasibility of coronary stenting in unprotected left main coronary artery disease in the real world clinical practice--a single center experience. AKI, BMI, CHF, ECMO, NSTEMI, WBC
76  2014 Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis. CI, DES, DS, MACE, OR, PCI, ss, TLR/TVR
77  2014 Unprotected left main coronary artery percutaneous coronary intervention in a pediatric patient with cardiac allograft vasculopathy. CAV, OHT, PCI
78  2013 A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction. AMI, CI, PCI
79  2013 Acute myocardial infarction due to left main coronary artery disease: a large multicenter national registry. MI, PCI, STEMI
80  2013 Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. CABG, COPD, LVEF, PCI
81  2013 Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience. AMI, CABG, PCI, TIMI
82  2013 Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. SES, TLR
83  2013 Comparison of sirolimus-, paclitaxel-, and everolimus-eluting stent in unprotected left main coronary artery percutaneous coronary intervention. DES, EES, PCI, PES, SES
84  2013 Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. CVA
85  2013 Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry). MACE, SES
86  2013 Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients. CABG, DES, MACCE, OR, PCI, TVR
87  2013 Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. DES, ISR, PCI, TBL, TLR
88  2013 Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population. MACE, PCI, TFA, TRA
89  2013 Long term clinical outcomes in DES implantation for unprotected left main disease. DES, PCI, PES, ST, TLR, TVR
90  2013 Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. CI, DES, HR, PCI
91  2013 New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry. DES, MACEs, MI, PCI, ST, TVR
92  2013 Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. DES, MACCE, MI, nLMCA, PCI, TVR
93  2013 Outcomes of coronary artery interventions: comparing coronary artery bypass surgery and percutaneous coronary intervention in patients with unprotected left main stenosis. CABG, PCI
94  2013 Percutaneous coronary intervention of unprotected left main disease: five-year outcome of a single-center registry. MACE, MI, PCI, TLR
95  2013 Unprotected left main coronary artery disease. Surgical therapy. CABG
96  2013 Unprotected left main PCI: status report 2013. PCI
97  2013 Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. CI, EES, ZES
98  2012 A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease. CABG, DESs, EuroSCORE, PCI, SYNTAX
99  2012 Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. CI, HRs, IPW, PCI
100  2012 Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. MACE